Back to directory listing

Dr Harren Jhoti FRS FMedSci

Job Title
President and CEO

Astex Pharmaceuticals
Year elected



Drug discovery, structural biology, oncology, fragment-based drug discovery.

Section committee elected by

Physics, chemistry, biochemistry, structural biology, mathematics, informatics and engineering applied to biomedicine

Harren Jhoti is President and CEO of Astex Therapeutics, a small biotech he co-founded and where he has been a pioneer of new approaches to structure-guided drug discovery. Here he first demonstrated the power of fragment-based approaches using X-ray crystallography to make new medicines. Dr Jhoti designed and developed a vibrant fragment discovery platform from which multiple small molecule drug candidates were generated, validating this new approach and helping it gain acceptance within industry and academia, including seminal research publications. Several of these drug candidates in development continue to be progressed by pharmaceutical partners, such as Novartis and AstraZeneca, and have shown clinical benefit in cancer patients.

Hamied Foundation UK-India Antimicrobial Resistance Meeting 2019

Book Now

Mentoring Masterclass, February 2019, Bristol

Book Now

The future of gene therapies: next steps for the UK

Book Now
View more
FB Twitter Instagram Youtube